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THE integrity of the bacterial cell wall depends on the balanced
action of several peptidoglycan (murein) synthesizing and degrad-
ing enzymes1,2.Penicillin inhibits the enzymes responsible for pep-
tide crosslinks in the peptidoglycan polymer3. Enzymes that act
solely on the glycosidic bonds are insensitive to this antibiotic, thus
offering a target for the design of antibiotics distinct from the β-
lactams. Here we report the X-ray structure of the periplasmic
soluble lytic transglycosylase (SLT; Mr 70,000) from Escherichia
coli. This unique bacterial exomuramidase cleaves the β-1,4-glyco-
sidic bonds of peptidoglycan to produce small 1,6-anhydro-
muropeptides4-6.The structure of SLT reveals a 'superhelical' ring
of a-helices with a separate domain on top which resembles the
fold of lysozyme. Site-directed mutagenesis and a crystallographic
inhibitor-binding study confirmed that the lysozyme-like domain
contains the active site of SLT.
Details of the structure determination are shown in Table I.
The unusually shaped SLT molecule is built up of three domains,
which are all very rich in a-helices (Fig. I). In total, about 63%
of all amino-acid residues are in a-helices, the remaining residues
being mostly in the helix-connecting turns and loops. The N-ter-
minal domain (residues 1-360) contains 22 a-helices packed in
an extended, V-shaped conformation. This V-domain is con-
nected by a long loop of ~20 residues to a small linker domain
(residues 381-450) of four a-helices. Together these first two
domains form a closed ring with a large central hole (Fig. la, e).
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The C-terminal domain (C-domain; residues 451-618) is packed
on top of this ring (Fig. Ib), interacting with part of the linker
domain and the C-terminal region of the V-domain. It has a
globular structure, containing nine a-helices, but also includes
a very irregular sheet of three small anti parallel β-strands. Over-
all, the SLT molecule can be described as an asymmetrically
shaped doughnut with dimensions of ~85 x 75 x 55 Å. The cen-
tral hole has a diameter varying from 25 to 35 Å.
The a-helices in the ring-shaped V and linker domains form
a double-layered right-handed superhelix. Helices in either layer
of this superhelix run parallel to each other, but antiparallel to
the helices of the other layer (Fig. Ie). The exception is helix
H12, which is inserted as an antiparallel helix in the outer layer,
permitting the curve in the V-domain. The helix-to-helix packing
in the first two domains of SLT is distinct from that observed
in four-a-helix bundles, for which structurally adjacent helix
pairs are all antiparallel7. This superhelix of helices is not unique,
however, having first been observed in the crystal structure of
the lipovitellin-phosvitin complex from lamprey yolkS. Stabil-
ization is provided by the burying of hydrophobic residues at
the helical interfaces and by specific main chain-side chain and
side chain-side chain interactions between residues of adjacent
helices (Fig. Id). There is a disulphide bridge between residues
106 and 139 connecting helices H7 and H9. In addition, proline
residues are probably important for tightening of the V-domain,
especially in the first half where nearly every helix-connecting
loop contains one or two of these residues. One proline residue
is located in the middle of helix H15, which shows a pronounced
kink. Similar kinks in a-helices, caused by internal prolines, have
been noted in a number of other proteins9,1O.
The C-domain of SLT resembles the fold of lysozyme. Figure
2a and b shows a superposition of the C-domain of SLT on hen
egg-white lysozyme 1 (HEWL) and lysozyme from bacterio-
phage T4 (T4L; ref. 12). The structural similarity is remarkable
in view of the absence of any significant sequence homology.
We showed that the active site ofSLT is located in the C-domain
by difference Fourier analysis of an SLT-inhibitor complex at
3.5 Å resolution (Fig. 3b, e). Although a more detailed analysis
of the SLT-inhibitor complex awaits data at higher resolution,
preliminary results confirm the similarity with the Iysozymes.
The glucosaminyl part of the inhibitor is bound at a position
similar to subsite C in the active sites of HEWL and T4L,
whereas the proline part is bound close to Glu 478 occupying a
region analogous to subsite D in the Iysozymes. Glu 478 in SLT
most probably functions as the 'catalytic' acid. In the structure
alignment it coincides with both the 'catalytic' glutamic acid of
HEWL (Glu 35) and that ofT4L (Glu II). Moreover, mutation
of this residue to a glutamine gave a completely inactive enzyme,
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in line with a role as protein donor in a lysozyme-like reaction
mechanism 13 In contrast, there is no residue in the β-sheet of
SLT that could take up the role of the catalytic aspartate of the
lysozymes. Instead, coming from the upper lobe of the C-
domain, the carboxylate from Glu 583 is close to the presumed
reaction centre (Fig. 2). Its negative charge is, however, not
critical, as a E583Q (Glu --> Gin) mutant still has considerable
catalytic activity. But it may be argued that there should be no
strict requirement for a second carboxylate group in the catalytic
mechanism of SLT. In SLT the intramolecular C6-hydroxyl
group of saccharide 0, rather than a water molecule, appears
to be the nucleophile that attacks the Cl carbon of a possible
FIG. 1 a, A ribbon stereo representation of the model of SLT generated
using the program MOLSCRIPT24.The colour assignment is as follows:
blue, the N-terminal or U-domain; green, the linker domain; yellow, the
C-terminal or C-domain. The N terminus of the polypeptide chain is
located at the lower end of the U-domain. The C terminus is located at
the top part of the C-domain near the U-C domain interface. Also shown
are the atoms of the single disulphide bridge in SLT formed by residues
106 and 139 in helices H7 and H9 of the U-domain. b, Edgewise view
of the SLT doughnut, showing the C-domain located on top of the helical
ring. The active site of SLT is located in the groove of the C-domain
flanked by the three-stranded β-sheet. c, Schematic representation of
the U and linker domains of SLT illustrating the double-layered 'super-
helical' packing of the a-helices. The two layers are identified by differ-
ent colours of the helices. Residues 361 to 380 form an extended
interdomain loop that is wrapped around part of the C-domain in the
complete SLT molecule. d, A 2.7 A (2Fo - Fe) electron density map calcu-
lated with refined model phases and contoured at 1σ, displaying part
of the interface of helices H8, H9 and H10 (residues 129 to 165).
Possible hydrogen-bond contacts between side-chain and main-chain
atoms are indicated by dashed lines.
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FIG. 2 Backbone comparison of the Codomain
of SLT with lysozyme from hen eggo
white (a) and lysozyme from bacteriophage
T4 (b) using the Rossmann-Argos alignment
method25. The aocarbon backbone of the C-
domain of SLT is represented by dark solid
spheres connected by thick lines, the backo
bone of the lysozymes by open spheres and
thin lines. Residue numbers refer to the SLT
sequence. The overall structure of the Co
domain clearly shows most of the features
common to the lysozyme fold: it is ellipsoidal
in shape with two lobes linked by a long ao
helix. A deep groove separates the two lobes.
The lower N-terminal lobe includes some hel-
ices and a very irregular sheet of three small,
antiparallel βostrands. The upper Coterminal
lobe is predominantly helical, built up of five
different a-helices. Unique features of the
SLT Codomain that have no counterpart in
either of the two Iysozymes include the region
between the βosheet and the longer linker
helix, and the last regions of the Coterminal
lobe. Also shown are the side chains of
Glu 478 and Glu 583 in SLT (dark solid
atoms) compared with those of the catalytic
residues in the Iysozymes (E35/D5 2 and
E11/D 20 for HEWL and T4L, respectively).
Coordinates for the lysozymes were obtained
from the Protein Data Bank26.
FIG. 3 a, Chemical structure of the muropeptide
product of the reaction catalysed by SLT. The
reaction product consists of a disaccharide of
Noacetylglucosamine and Noacetylmuramic acid
with an intramolecular anhydroobond between C1
and C6. The C30lactyl group of the muramic acid
is linked to an oligopeptide (R), consisting of L-
alanine, Doglutamic acid, mesoodiaminopimelic
acid and Doalanine residues. The peptide may
be crosslinked to that of another disaccharide
forming dimeric muropeptides5. b, Structure of
bulgecin A. This compound is a bacterial
metabolite produced by Pseudomonas acido-
phifa and mesoacidophifa, which has bUlge-
inducing and lysisoenhancing activity when used
in combination with β-lactam antibiotics27.
Recently it has been found that SLT is inhibited
by bulgecin A28. c, Stereographic view of a 3.5oÅ
(Fo - Fc)exp(iac) difference electron density map
of the SLT-bulgecin complex, contoured at 1.5σ,
showing the bulgecin A inhibitor bound in the
active site of SLT (Fo represents the observed
structure factor amplitudes for the SLT-bulgecin
complex, Fc and ac are calculated structure factor
amplitudes and phases from the refined, uncom-
plexed model). Residues in the active site of SLT
that might interact with bulgecin A are indicated.
The inhibitor was soaked into the crystals of
native SLT for  2days (7 mM inhibitor in a solution
of 40% ammonium sulphate in 0.1 M sodium
acetate, pH 5.0). Diffraction data to 3.3 Å resoluo
tion were collected on a FAST area detector and
merged using programs of the Groningen
BIOMOL crystallographic package (Rme,ge =
8.1%).
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TABLE 1 Data collection and phasing statistics
Pt(ethylene)
Native-I Native-II KAuCI4-1 KAuCI4-11 (NH3)2CI2
Data collection
Resolution (Å) 3.1 2.7 3.1 3.0 3.1
Observations (no.) 42,639 132,289 23,051 16,287 24,639
Unique reflections (no.) 15,409 32,225 11,062 8,232 12,616
Completeness (%) 87 96 61 45 71
Rmerge * 0.052 0.072 0.080 0.110 0.044
Rderivt 0.17 0.22 0.12
Concentration of HA (mM)‡ 2 2 0.5
Phasing statistics
Resolution included (Å) 3.3 3.5 3.3
Heavy-atom sites 3 3 5
Occupancies Or/Oa§ 36.1/4.8 28.7/6.1 21.4/3.0
RCull's|| 0.57 0.69 0.62
Phasing power" 2.2 1.0 1.9
Native SLT was prepared and crystallized as described6.17. The spacegroup is P212121 with cell dimensions a =80.8 Å, b=88.4 Å and c= 132.1 Å.
Native and derivative data used in isomorphous replacement were measured on a FAST area detector (Enraf-Nonius, Delft, The Netherlands)
connected to an Elliot GX-21 rotating anode generator, and reduced using the programs MADNES18, XDS19 and software of the Groningen BIOMOL
package. For the KAuCl4 derivative, an additional data set (KAuCI4-11)was collected on the FAST system of the Brookhaven National Laboratory
X12C beamline at the NSLS, Upton, NY. Native data to 2.7 Å were collected on the MAR Research image plate system at the synchrotron beamline
X31 of the EMBL Outstation at DESY, Hamburg. Evaluation and reduction of these data were carried out using modified versions of the MOSCO
programs (Hamburg, Germany) and programs of the CCP4 suite (Daresbury, UK). Heavy-atom parameters were refined with PHARE2o.A map was
calculated to 3.3 Å which had a mean figure-of-merit of 0.60 for 10,396 reflections between 35.0 and 3.3 Å resolution. The map was improved by
solvent flattening and an initial protein model was fitted to the density using FROD021 and 022. The model was gradually improved by energy
minimization using X_PLOR23alternated with model-building sessions in maps calculated with combined phases. A few rounds of simulated annealing
refinement improved the model further. In the last stages of refinement, some water molecules were added, based on peaks in (Fo - Fc) difference
Fourier maps higher than 30" and requiring at least two favourable hydrogen-bonding interactions with protein atoms. The present model contains
all 618 residues and 22 water molecules. No breaks in the electron density were observed at the 10" level for the entire polypeptide backbone
except at residue 371, which forms part of a long extended loop connecting the first two domains. The current R-factor for 22,643 reflections
between 8.0 and 2.7 Å resolution (F≥20"(F)) is 22.8% after a restrained B-factor refinement. Root-mean-square deviations from ideality in bond
lengths and angles are 0.019 Å and 3.6°, respectively.
* Rme,ge= ΣhΣi|I(h,i) - <1>(h)|/ΣhΣ;(I>(h); I(h,i) is the scaled intensity of the ith observation of reflection hand <1>(h) is the mean value.
† Rde"v= Σh IFPH- Fp I/ΣhFP; FpHand Fp are the structure factor amplitudes for native and derivative data.
H For data collection and soaking experiments involving heavy atoms (HAs), crystals of SLT were transferred to a stabilizing solution of 40%
saturated ammonium sulphate in 0.1 M sodium acetate buffer, pH 5.0.
§ Or and Oa represent real and anomalous occupancy of the strongest heavy-atom site in arbitrary units, proportional to the number of electrons.
II RCullis= Σh I|FpH,obs± Fp.obs|- FH,calc|/Io |FPH,Obs± Fp.obs|;for centric reflections only.
¶ Phasing power = [Σh IFH.calcI2/Σh(|FPH.ObS|-I FpH,calc|)2]1/2.
oxocarbonium intermediate (Fig. 3a). Such an intramolecular
attack would probably require a shorter lifetime of the oxocar-
bonium intermediate, and thus less stabilization, as the reaction
is no longer dependent on the diffusion-controlled replacement
of the leaving group with a water molecule14,15.
The crystal structure of SLT will be used for the design of
specific inhibitors that might form a basis for the development
of novel types of antibiotics. Meanwhile, further research is
needed to obtain more information about the mechanism of
peptidoglycan binding and cleavage. Most intriguing is the ques-
tion of the function of the U and linker domains. They might
be needed to enhance substrate affinity by providing additional
murein-binding sites. In addition, the central hole could impose
exo-enzymatic activity16 upon the lysozyme-like C-domain:
indeed, the active-site groove in the C-domain is oriented in such
a way that a glycan strand bound with its GlcNAc end towards
site A would run with its other end through the central hole,
close to the surface of the linker domain. 0
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